All In MedTech

FDA Clearance Tracker · N970012-S161

AMS Ambicor Inflatable Penile Prosthesis

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 28, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 28, 2019

Approved

Time to decision

16 days

Received Mar 12, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
N970012-S161
Device name
AMS Ambicor Inflatable Penile Prosthesis
Applicant location
Marlboro, MA
Received
Mar 12, 2019
Decided
Mar 28, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
N970012

Device type

Device class
Class III
Regulation
21 CFR 876.3350

Every decision under product code JCW

FDA's approval statement

As written in FDA's record.

Approval for a sterilization site change for approval of BSC Coventry, Rhode Island as an additional sterilization site for ethylene oxide (EO) Cycle 101 due to the closure of the Sterigenics Willowbrook facility.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.